| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D419-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2009508833-A |
| titleOfInvention |
Pyrimidine derivatives for inhibition of IGF-1R tyrosine kinase activity |
| abstract |
A compound of formula (I) {wherein the substituents are as defined herein) for use in inhibiting the activity of insulin-like growth factor 1 receptor in warm-blooded animals such as humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9187453-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013146963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012521425-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012521426-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013180183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013146963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013180183-A1 |
| priorityDate |
2005-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |